ECTRIMS
The European Committee for Treatment and Research in Multiple Sclerosis
The European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) is a non-profit, independent, representative European-wide organisation that serves as Europe’s and the world’s largest professional organisation dedicated to the understanding and treatment of multiple sclerosis (MS).
The ECTRIMS Online Library offers access to the abstracts, webcasts, ePosters, and presentations from ECTRIMS past recent congresses. Content can be sorted by events, contributors, and content type to facilitate the online search.
Focused Workshop 2021
ECTRIMS
2021 Data on Infections Associated With Multiple Sclerosis Disease-Modifying Treatments: ECTRIMS Session Summary
FEATURING
Maria Pia Amato,
Alexey Boyko
- 9 views
- September 30, 2021
ECTRIMS
Management of Infectious Risks in Multiple Sclerosis During the COVID-19 Pandemic: ECTRIMS Session Summary 2021
FEATURING
Maria Pia Sormani,
Bruno Stankoff
- 4 views
- September 30, 2021
ECTRIMS
2021 Immunization Strategies for Patients With Multiple Sclerosis: ECTRIMS Session Summary
FEATURING
Mar Tintoré,
Sandra Vukusic
- 4 views
- September 30, 2021
ECTRIMS
Recommendations for the Management of Infectious Risks in Routine Multiple Sclerosis Clinical Practice: MS Physician Perspective
FEATURING
Ludwig Kappos
- 4 views
- September 30, 2021
ECTRIMS
Safety and Immunogenicity of Vaccines in Multiple Sclerosis
FEATURING
Christine Lebrun-Frénay
- 8 views
- September 30, 2021
ECTRIMS
Immunization Strategy in Patients With Multiple Sclerosis: Before, During, and After Immunosuppression
FEATURING
Susana Otero Romero
- 44 views
- September 30, 2021
ECTRIMS
Vaccination in Children on Multiple Sclerosis Disease Modifying Therapies
FEATURING
Yael Hacohen
- 145 views
- September 30, 2021
- 1
ECTRIMS
Immunization Strategies in Women and Pregnant Women With Multiple Sclerosis
FEATURING
Melinda Magyari
- 6 views
- September 30, 2021
ECTRIMS
Immunization Strategies in Elderly Patients With Multiple Sclerosis
FEATURING
Bernhard Hemmer
- 5 views
- September 30, 2021
ECTRIMS
Immunization Recommendations for Patients With Multiple Sclerosis Traveling Internationally: ECTRIMS Focused Workshop April 2021
FEATURING
Mauricio Farez
- 10 views
- September 30, 2021
ECTRIMS
COVID-19 and Immunological Response in Multiple Sclerosis: B Cells and Risk of Reinfection
FEATURING
Heinz Wiendel
- 13 views
- September 30, 2021
ECTRIMS
COVID-19 and Multiple Sclerosis Clinical Characteristics and Outcomes: Data From the COVISEP Registry
FEATURING
Céline Louapre
- 5 views
- September 30, 2021
ECTRIMS
Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis: An International Cross-Sectional Study
FEATURING
Steve Simpson-Yap
- 35 views
- September 30, 2021
ECTRIMS
Challenges With COVID-19 Vaccines in the Multiple Sclerosis Population
FEATURING
Hesham Abboud
- 56 views
- September 30, 2021
ECTRIMS
Genetic and Immunological Causes of Life-Threatening COVID-19: COVID Human Genetic Effort
FEATURING
Jean-Laurent Casanova
- 2 views
- September 30, 2021
ECTRIMS
Management of Multiple Sclerosis and COVID-19: ECTRIMS Workshop 2021 Roundtable Discussion
FEATURING
Céline Louapre,
Hesham Abboud
- 8 views
- September 30, 2021
ECTRIMS
Infectious Risks in Paediatric MS Patients Planning to Start or Receiving Immunosuppressive or Immunomodulatory Treatments
FEATURING
Yael Hacohen
- 6 views
- September 30, 2021
ECTRIMS
Infectious Risks in Pregnant Women With Multiple Sclerosis Planning to Start or Receiving Immunosuppressive or Immunomodulatory Treatments
FEATURING
Ruth Dobson
- 5 views
- September 30, 2021
ECTRIMS
Disease Modifying Therapies, Advanced Age, and Comobidities on the Risk of Infections in Multiple Sclerosis
FEATURING
Kathryn Fitzgerald
- 5 views
- September 30, 2021
ECTRIMS
Risk of Infections in Latin American Patients With Multiple Sclerosis
FEATURING
Maria Zuluaga Rodas
- 4 views
- September 30, 2021
ECTRIMS
Multiple Sclerosis Disease Modifying Treatments and Associated Risk of Infections in India
FEATURING
Lekha Pandit
- 11 views
- September 30, 2021
ECTRIMS
Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis: Risk, Prevention, and Management
FEATURING
David Clifford
- 103 views
- September 30, 2021
ECTRIMS
Infections Associated With S1P Modulators in Patients With Multiple Sclerosis
FEATURING
Matthias Mehling
- 50 views
- September 30, 2021
ECTRIMS
Infections Associated With Anti-CD52 Lymphodepleting Therapies in Patients With Multiple Sclerosis
FEATURING
Krzysztof Selmaj
- 6 views
- September 30, 2021
ECTRIMS
Infections in Patients With Multiple Sclerosis Using Anti-CD20 Therapies
FEATURING
Fredrik Piehl
- 61 views
- September 30, 2021
ECTRIMS
Infection Risk Associated With New NMOSD Treatments: Anti-CD19 (Inebilizumab), Eculizumab and Satralizumab
FEATURING
Brian Weinshenker
- 80 views
- September 30, 2021
ECTRIMS
Risk of Infections Associated With Multiple Sclerosis Disease-Modifying Treatments in the Era of COVID-19: ECTRIMS Workshop 2021 Roundtable Discussion
FEATURING
David Clifford,
Matthias Mehling,
Krzysztof Selmaj,
Per Soelberg Sorensen,
Fredrik Piehl,
Brian Weinshenker
- 9 views
- September 30, 2021